Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15010 total
CRWV enters the second week of July with short interest rebuilding sharply and the stock down 16% on the week — a combination that marks a clean break from the ambiguous data picture that clouded last week's notes. The…
SoFi Technologies drops 4.6% on Tuesday to $17.75, with three weeks to the July 27 earnings print and a short base that has quietly grown while every options alarm has faded. Short interest is the dominant story here,…
ROKU heads into its July 31 earnings report with short sellers quietly rebuilding positions, the Street turning more cautious, and insiders selling into strength — an unusual convergence of hesitation at $141. Short…
Synchrony Financial enters its July 20 Q2 earnings print with the Street in an unusually constructive mood — two firms raised price targets on the same morning this week, even as the stock dipped nearly 2% on the…
QUALCOMM is grinding lower into its July 29 earnings date, down another 1.2% on the week and 14% over the past month, while analysts who rushed to raise targets last week have yet to find much buyer response. The…
Akamai Technologies enters the week before its August 4 earnings with a peculiar split personality: short sellers are deeply embedded at 13.3% of the float but making no new moves, while options traders are piling into…
Qnity Electronics spent last week defying the sector selloff; this week it made up the deficit all at once, dropping 14% while its semcap peers collapsed in unison. The relative-underperformance story from last week…
PACS Group heads into its August earnings window with an unusual tension: the Street's conviction is building, but the founder is quietly cashing out at the top. The analyst story is unambiguously bullish — and it…
GE Vernova has erased most of last week's 13.5% surge in a single week, dropping 8.3% to $1,077.08 — with 6.5% of that gone in Tuesday's session alone — arriving at Q2 earnings on July 22 in a meaningfully weaker…
Intuitive Machines has shed another 17% this week, closing at $17.85, as the themes flagged in last week's note — heavy insider selling and a rebuilding short book — continue to define the tape. The short position…
Healthcare Realty Trust heads into its July 30 earnings with short sellers rebuilding positions, analysts cautiously lifting targets, and a divergence opening between the stock's gradual recovery and the Street's…
Corebridge Financial heads into its August 4 Q1 results with the Street turning more constructive — even as the stock's strongest month in recent memory raises the bar for what the print needs to deliver. The analyst…
JEPQ pulled back 3.5% this week to close at $59.32, a modest dip for a covered-call income ETF that has otherwise outperformed pure Nasdaq beta through the first half of 2026 — and the most interesting story this week…
BTSG heads into its July 30 earnings with one of the most consistently bullish analyst tapes in healthcare services — and a stock that has already moved 22% higher in a month. The analyst conviction story is unusually…
CGDV, Capital Group's dividend value ETF, enters the second week of July with its lending market almost unrecognisably calmer than it was a month ago — and that swing tells a more interesting story than the fund's…
CGGR, the Capital Group Growth ETF, tells an interesting story this week — not in its price, which slipped just 1.1%, but in a dramatic reversal in its borrow market conditions that happened almost overnight at the…
MDA Space heads into the week of July 8 with a clear internal contradiction: the fundamental story remains strong, but insiders are selling into strength and short sellers just made their largest single-day addition in…
Alignment Healthcare enters the final stretch before its July 30 earnings report with a striking divergence: the stock has surged 56% over the past month, yet virtually every senior insider has been selling into the…
Tarsus Pharmaceuticals is having its best week in months, with the stock up 12% to $70.55 — and the more interesting question is whether the options market's retreat from caution reflects genuine conviction or simply…
JEPI enters the second week of July with an unusual split: options traders are the most bullish they've been in months, while the borrow market quietly tightens beneath the surface. The options picture is the clearest…
